674 Topoisomerase II alpha (TOP2A) alterations as a predictive marker for epirubicin sensitivity in 805 high-risk breast cancer patients. A randomised DBCG trial (DBCG89D)

2003 ◽  
Vol 1 (5) ◽  
pp. S202-S203 ◽  
Author(s):  
A. Knoop ◽  
H. Knudsen ◽  
E. Balslev ◽  
B. Rasmussen ◽  
J. Overgaard ◽  
...  
Author(s):  
Brigitte Rack ◽  
Christian Schindlbeck ◽  
Julia Jückstock ◽  
Ulrich Andergassen ◽  
Philip Hepp ◽  
...  

2007 ◽  
Vol 13 (10) ◽  
pp. 2977-2985 ◽  
Author(s):  
Teresa A. Gilewski ◽  
Govind Ragupathi ◽  
Maura Dickler ◽  
Shemeeakah Powell ◽  
Sonal Bhuta ◽  
...  

2002 ◽  
Vol 11 (2) ◽  
pp. 415-421 ◽  
Author(s):  
Kenneth R. Meehan ◽  
Rebecca Slack ◽  
Edmund Gehan ◽  
Herbert B. Herscowitz ◽  
Ellen M. Areman ◽  
...  

Brachytherapy ◽  
2010 ◽  
Vol 9 (2) ◽  
pp. 171-177 ◽  
Author(s):  
Richard B. Wilder ◽  
Lisa D. Curcio ◽  
Rajesh K. Khanijou ◽  
Martin E. Eisner ◽  
Jane L. Kakkis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document